Another small molecule SBI‐0640756 (SBI‐756), as a first‐in‐class inhibitor targeting EIF4G1 and disrupting the EIF4F complex, showed inhibitory effects on tumour growth.41 This evidence concerns the gene EIF4E and neoplasm.